Skip to main content
. 2018 Feb 23;8:3575. doi: 10.1038/s41598-018-21983-w

Table 1.

Demographic and health characteristics of participants with cognitive impairment vs. normal cognition.

Risk factors Cognitive Impairment (n = 144) Normal Cognition (n = 336) p-value
Sociodemographic and behavioral features
Gender <0.001
  Men 41(28.5%) 174(51.8%)
  Women 103(71.5%) 162(48.2%)
Age (year) 0.094
  ≤85 82(56.9%) 223(66.4%)
  ≥86 59(43.1%) 112(33.6%)
Education
 Elementary school or less 106(73.6%) 200(59.5%) 0.001
  Middle school 33(22.9%) 91(27.1%)
 At least some high school 5(3.5%) 45(13.5%)
Marital Status <0.001
  Solitary 107(74.3%) 141(42.0%)
  Non-solitary 37(25.7%) 195(58.0%)
Monthly income (Chinese yuan) 0.001
  ≤2000 53(37.9%) 85(27.6%)
  2000–4000 82(58.6%) 181(58.8%)
  >4000 5(3.5%) 42(13.6%)
Body Mass Index (kg/m2) 0.002
  Normal (BMI <24) 93(64.6%) 173(51.5%)
 Overweight (BMI ≥24) 41(35.4%) 151(48.5%)
Smoking 0.334
  Never smoker 122(84.7%) 264(78.6%)
  Ever smoker 14(9.7%) 49(14.6%)
  Current smoker 8(5.6%) 23(6.8%)
Drinking 0.161
  Never drinker 134(93.1%) 293(87.2%)
  Ever drinker 7(4.9%) 27(8.0%)
  Current drinker 3(2.0%) 16(4.8%)
Physical activity 0.006
  <60 min per day 85(59.0%) 151(44.9%)
  ≥60 min per day 59(41.0%) 185(55.1%)
Medical history
  Hypertension 70(48.6%) 205(61.0%) 0.016
  Diabetes 26(18.1%) 53(15.8%) 0.502
  Dyslipidemia 13(9.0%) 49(14.6%) 0.135
 Coronary heart disease 28(19.4%) 90(26.8%) 0.105
 Chronic obstructive pulmonary disease 8(5.6%) 11(3.6%) 0.306
  Tumor 2(1.4%) 12(3.6%) 0.314
 Chronic kidney disease 2(1.4%) 11(3.3%) 0.314
  Other diseases 13(7.1%) 16(4.8%) 0.246
Medications
  Antidiabetic 23(16.0%) 46(13.7%) 0.514
  Antihypertensive 60(41.7%) 205(61.0%) <0.001
 Lipid lowering drugs 3(2.1%) 32(9.5%) 0.004
  Anticoagulation 24(16.7%) 78(23.5%) 0.105
  Diuretics 5(4.2%) 17(5.1%) 0.491

Categorical variables were presented as count and column percent.